Sagimet Biosciences Inc. Operating Lease, Liability in USD from Q4 2022 to Q4 2024

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Sagimet Biosciences Inc. quarterly Operating Lease, Liability history and growth rate from Q4 2022 to Q4 2024.
Sagimet Biosciences Inc. Operating Lease, Liability for the quarter ending December 31, 2024 was $78K, a 20% increase year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Growth (%)

Sagimet Biosciences Inc. Quarterly Operating Lease, Liability (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2024	$78K	+$13K	+20%	Dec 31, 2024	10-K	2025-03-12
Q4 2023	$65K	-$146K	-69.2%	Dec 31, 2023	10-K	2024-03-25
Q3 2023	$103K			Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$140K			Jun 30, 2023	10-Q	2023-08-21
Q4 2022	$211K			Dec 31, 2022	10-Q	2023-11-13

* An asterisk sign (*) next to the value indicates that the value is likely invalid.